BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 10519551)

  • 1. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
    Onichtchouk D; Chen YG; Dosch R; Gawantka V; Delius H; Massagué J; Niehrs C
    Nature; 1999 Sep; 401(6752):480-5. PubMed ID: 10519551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
    Takumi T; Moustakas A; Lin HY; Lodish HF
    Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.
    Mazerbourg S; Hsueh AJ
    Hum Reprod Update; 2006; 12(4):373-83. PubMed ID: 16603567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergence and convergence of TGF-beta/BMP signaling.
    Miyazono K; Kusanagi K; Inoue H
    J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of TGF-(beta) signalling by N-acetylgalactosaminyltransferase-like 1.
    Herr P; Korniychuk G; Yamamoto Y; Grubisic K; Oelgeschläger M
    Development; 2008 May; 135(10):1813-22. PubMed ID: 18417620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
    Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
    Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel type I serine-threonine kinase receptor Alk8 binds TGF-beta in the presence of TGF-betaRII.
    de Caestecker MP; Bottomley M; Bhattacharyya S; Payne TL; Roberts AB; Yelick PC
    Biochem Biophys Res Commun; 2002 May; 293(5):1556-65. PubMed ID: 12054694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An emerging complexity of receptors for transforming growth factor-beta.
    Derynck R; Chen RH; Ebner R; Filvaroff EH; Lawler S
    Princess Takamatsu Symp; 1994; 24():264-75. PubMed ID: 8983081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and regulation of the decoy bone morphogenetic protein receptor BAMBI in the developing avian face.
    Higashihori N; Song Y; Richman JM
    Dev Dyn; 2008 May; 237(5):1500-8. PubMed ID: 18386821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transcriptional partner for MAD proteins in TGF-beta signalling.
    Chen X; Rubock MJ; Whitman M
    Nature; 1996 Oct; 383(6602):691-6. PubMed ID: 8878477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A road map toward defining the role of Smad signaling in hematopoietic stem cells.
    Utsugisawa T; Moody JL; Aspling M; Nilsson E; Carlsson L; Karlsson S
    Stem Cells; 2006 Apr; 24(4):1128-36. PubMed ID: 16357343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and functional characterization of activin receptors.
    Mathews LS; Vale WW
    Receptor; 1993; 3(3):173-81. PubMed ID: 8167568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta receptors.
    Massagué J; Andres J; Attisano L; Cheifetz S; López-Casillas F; Ohtsuki M; Wrana JL
    Mol Reprod Dev; 1992 Jun; 32(2):99-104. PubMed ID: 1322148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the BMP-2-BRIA ectodomain complex.
    Kirsch T; Sebald W; Dreyer MK
    Nat Struct Biol; 2000 Jun; 7(6):492-6. PubMed ID: 10881198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble osteogenic molecular signals and the induction of bone formation.
    Ripamonti U
    Biomaterials; 2006 Feb; 27(6):807-22. PubMed ID: 16213014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling.
    Watanabe Y; Itoh S; Goto T; Ohnishi E; Inamitsu M; Itoh F; Satoh K; Wiercinska E; Yang W; Shi L; Tanaka A; Nakano N; Mommaas AM; Shibuya H; Ten Dijke P; Kato M
    Mol Cell; 2010 Jan; 37(1):123-34. PubMed ID: 20129061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of rat type I receptor cDNA for bone morphogenetic protein-2 and bone morphogenetic protein-4, and the localization compared with that of the ligands.
    Ikeda T; Takahashi H; Suzuki A; Ueno N; Yokose S; Yamaguchi A; Yoshiki S
    Dev Dyn; 1996 Jul; 206(3):318-29. PubMed ID: 8896987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor.
    Chen RH; Miettinen PJ; Maruoka EM; Choy L; Derynck R
    Nature; 1995 Oct; 377(6549):548-52. PubMed ID: 7566156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP signalling in early Xenopus development.
    Dale L; Jones CM
    Bioessays; 1999 Sep; 21(9):751-60. PubMed ID: 10462415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
    Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK
    J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.